Lopinavir/ritonavir: increased risk of bleeding in haemophilia

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2003年 / 982卷 / 1期

关键词：

Purpura; Ritonavir; Bleeding Complication; Indinavir; Saquinavir;

D O I：

10.2165/00128415-200309820-00010

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：4 / 4

相关论文

共 50 条

[41] Lopinavir/ritonavir: A protease-inhibitor combination
不详
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2001, 43 (1095): : 1 - 2
[42] Regimen simplification: Lopinavir/ritonavir with or without efavirenz
Pacios, Enrique
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2009, 27 (09): : 553 - 553
[43] Safety of lopinavir/ritonavir use in pregnancy investigated
Reactions Weekly, 2009, 1266 (1) : 5 - 5
[44] Unfavourable interaction of amprenavir and lopinavir in combination with ritonavir?
Mauss, S
Schmutz, G
Kuschak, D
AIDS, 2002, 16 (02) : 296 - 297
[45] Lopinavir–ritonavir in severe COVID-19
Hannah Stower
Nature Medicine, 2020, 26 : 465 - 465
[46] Ergotamine/lopinavir/ritonavir interactionErgotism: case report
Reactions Weekly, 2010, 1294 (1) : 18 - 18
[47] Lopinavir/ritonavir concentrations not linked to lipid abnormalities?
Reactions Weekly, 2004, 999 (1) : 5 - 5
[48] Comparison of different lopinavir/ritonavir resistance algorithms
Chantret, M
Chapplain, JM
Kerriguy, N
Guist'hau, O
Gicquel, J
Arvieux, C
Michelet, C
Ruffault, A
ANTIVIRAL THERAPY, 2002, 7 : S123 - S123
[49] Carbamazepine toxicity induced by lopinavir/ritonavir and nelfinavir
Bates, DE
Herman, RJ
ANNALS OF PHARMACOTHERAPY, 2006, 40 (06) : 1190 - 1195
[50] Risk factors for body fat composition changes in patients treated with lopinavir/ritonavir or nelfinavir
da Silva, B
King, M
Cernohous, P
Kelly, C
Tressler, R
Brun, S
ANTIVIRAL THERAPY, 2003, 8 (04) : L68 - L68

← 1 2 3 4 5 →